source
- FDA greenlights Motif Neurotech's feasibility trial of brain-implant hat for treatment-resistant depressionThe U.S. Food and Drug Administration has approved Motif Neurotech's request to begin an initial feasibility trial of its brain‑implant device aimed at patients with treatment‑resistant depression.…
- Trump administration cautions against federal funding for fentanyl test strips and other harm-reduction toolsThe federal agency that oversees addiction and mental health policy sent an open letter to its grant recipients warning them not to spend federal money on harm‑reduction supplies such as sterile sy…